{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:03:21Z","timestamp":1770350601633,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.thromres.2012.02.042","type":"journal-article","created":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T23:28:04Z","timestamp":1331940484000},"page":"e257-e262","source":"Crossref","is-referenced-by-count":40,"title":["Progestin-only contraception and venous thromboembolism"],"prefix":"10.1016","volume":"129","author":[{"given":"M.A.","family":"Blanco-Molina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Cristobal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.P.","family":"Pallardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Lete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2012.02.042_bb0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/13625180410001715681","article-title":"Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries","volume":"9","author":"Skouby","year":"2004","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.thromres.2012.02.042_bb0010","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0002-9378(99)70120-1","article-title":"The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices","volume":"181","author":"Rivera","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.thromres.2012.02.042_bb0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0002-9378(77)90295-2","article-title":"The effect of contraceptive steroids on hypothalamic-pituitary function","volume":"128","author":"Mishell","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.thromres.2012.02.042_bb0020","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/13625180400007736","article-title":"Clinical profile of contraceptive progestins","volume":"9","author":"Benagiano","year":"2004","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.thromres.2012.02.042_bb0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2105\/AJPH.81.1.90","article-title":"Trends in the content and use of oral contraceptives in the United States 1964\u201388","volume":"81","author":"Gerstman","year":"1991","journal-title":"Am J Public Health"},{"key":"10.1016\/j.thromres.2012.02.042_bb0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0010-7824(99)00101-8","article-title":"Nomenclature of the gonane progestins","volume":"60","author":"Edgren","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2012.02.042_bb0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Hum Reprod Update"},{"issue":"Suppl. 2","key":"10.1016\/j.thromres.2012.02.042_bb0040","first-page":"574","article-title":"Counselling women about hormonal therapy","volume":"123","author":"Martinelli","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2012.02.042_bb0045","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1160\/TH08-10-0684","article-title":"Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry","volume":"101","author":"Blanco-Molina","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2012.02.042_bb0050","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2006.12.018","article-title":"Range of published estimates of venous thromboembolism incidence in young women","volume":"75","author":"Heinemann","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2012.02.042_bb0055","first-page":"488","article-title":"Hormone therapy and thromboembolic disease","volume":"14","author":"Battaglioli","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.thromres.2012.02.042_bb0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0037-1613960","article-title":"A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways","volume":"84","author":"Tans","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2012.02.042_bb0065","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0015-0282(16)42793-7","article-title":"Ethinyl estradiol and dl-norgestrel as a postcoital contraceptive","volume":"28","author":"Yuzpe","year":"1977","journal-title":"Fertil Steril"},{"key":"10.1016\/j.thromres.2012.02.042_bb0070","first-page":"538","article-title":"Emergency contraception and retinal vein thrombosis","volume":"82","author":"Lake","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.thromres.2012.02.042_bb0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0010-7824(99)00011-6","article-title":"The risk of venous thromboembolism in users of postcoital contraceptive pills","volume":"59","author":"Vasilakis","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2012.02.042_bb0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1160\/TH06-09-0540","article-title":"Rapid activation of haemostasis after hormonal emergency contraception","volume":"97","author":"van Rooijen","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2012.02.042_bb0085","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.maturitas.2003.09.016","article-title":"Differential effects of progestins on hemostasis","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.thromres.2012.02.042_bb0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/ob.1998.v179.a92633","article-title":"Effects on haemostatic variables of desogestrel and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: A review","volume":"179","author":"Winkler","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.thromres.2012.02.042_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5122(96)00994-2","article-title":"Effects of progestin on hemostasis","volume":"24","author":"Kuhl","year":"1996","journal-title":"Maturitas"},{"key":"10.1016\/j.thromres.2012.02.042_bb0100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0010-7824(98)00045-6","article-title":"A randomized controlled double-blind study of effects on hemostasis of two progesterone-only pills containing 75 \u03bc desogestrel or 30 \u03bc levonorgestrel","volume":"57","author":"Winkler","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2012.02.042_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.contraception.2004.02.010","article-title":"Venous thromboembolic disease in users of low-oestrogen combined oestrogen-progestin oral contraceptives","volume":"70","author":"Sidney","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2012.02.042_bb0110","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case\u2013control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2012.02.042_bb0115","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1253\/circj.71.1765","article-title":"Pulmonary embolism is an important cause of death in young adults","volume":"71","author":"Sakuma","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.thromres.2012.02.042_bb0120","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10654-005-4266-7","article-title":"Mortality from venous thromboembolism in young Swedish women and its relation to pregnancy and use of oral contraceptives\u2013an approach to specifying rates","volume":"20","author":"Samuelsson","year":"2005","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.thromres.2012.02.042_bb0125","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(00)02382-5","article-title":"Oral contraceptives and fatal pulmonary embolism","volume":"355","author":"Parkin","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2012.02.042_bb0130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0010-7824(98)00041-9","volume":"57","author":"World Health Organization CSoCDaSHC","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2012.02.042_bb0135","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)04394-9","article-title":"Risk of idiopathic venous thromboembolism in users of progestagens alone","volume":"354","author":"Vasilakis","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2012.02.042_bb0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/13625189909064007","article-title":"Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women","volume":"4","author":"Heinemann","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.thromres.2012.02.042_bb0145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case\u2013control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2012.02.042_bb0150","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/00016340902730375","article-title":"Limited knowledge on progestogen-only contraception and risk of venous thromboembolism","volume":"88","author":"Bergendal","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.thromres.2012.02.042_bb0155","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2004.07.009","article-title":"Progestogen-only contraception in women at high risk of venous thromboembolism","volume":"70","author":"Conard","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2012.02.042_bb0160","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1055\/s-2006-951455","article-title":"Thromboembolism in women","volume":"32","author":"Martinelli","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2012.02.042_bb0165","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.thromres.2010.08.010","article-title":"Is progestin an independent risk factor for incident venous thromboembolism? A population-based case\u2013control study","volume":"126","author":"Barsoum","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2012.02.042_bb0170","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device","volume":"30","author":"van Hylckama Vlieg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2012.02.042_bb0175","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"issue":"343","key":"10.1016\/j.thromres.2012.02.042_bb0180","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogen and oestrogen doses: Danish cohort study, 2001\u20139","volume":"25","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2012.02.042_bb0185","first-page":"1271","article-title":"Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives","volume":"85","author":"Aznar","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2012.02.042_bb0190","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1055\/s-0037-1615049","article-title":"Geographic distribution of the 20210 G to A prothrombin variant","volume":"79","author":"Rosendaal","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2012.02.042_bb0195","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-0038-1645218","article-title":"Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women","volume":"63","author":"Conard","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2012.02.042_bb0200","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/01.ATV.16.6.742","article-title":"Thrombotic risk in hereditary antithrombin III, protein C and protein S deficiency","volume":"16","author":"Pabinger","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2012.02.042_bb0205","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM200002103420602","article-title":"Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium","volume":"342","author":"Gerhardt","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2012.02.042_bb0210","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1055\/s-0037-1613085","article-title":"Inherited thrombophilia and first venous thromboembolism during pregnancy and puerpuerium","volume":"87","author":"Martinelli","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2012.02.042_bb0215","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1055\/s-0037-1614442","article-title":"Incidence of venous thromboembolism in families with inherited thrombophilia","volume":"81","author":"Simioni","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2012.02.042_bb0220","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0002-9378(98)70155-3","article-title":"Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations","volume":"179","author":"Grandone","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.thromres.2012.02.042_bb0225","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.contraception.2005.08.011","article-title":"Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review","volume":"73","author":"Mohllajee","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2012.02.042_bb0230","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Ledien mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2012.02.042_bb0235","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/bmj.313.7065.1127","article-title":"Factor V Leiden : should we screen oral contraceptive users and pregnant women?","volume":"313","author":"Vandenbroucke","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2012.02.042_bb0240","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/archinte.164.18.1965","article-title":"Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review","volume":"164","author":"Gomes","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2012.02.042_bb0245","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/GCO.0b013e32830ab83f","article-title":"Thrombophilias in adolescents: the past, present and future","volume":"20","author":"Dietrich","year":"2008","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.thromres.2012.02.042_bb0250","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1177\/0961203306071706","article-title":"Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil)","volume":"15","author":"Pisoni","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2012.02.042_bb0255","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/13625180400020952","article-title":"Depot-medroxyprogesterone acetate in anticoagulated patients with previous hemorrhagic corpus luteum","volume":"10","author":"S\u00f6nmezer","year":"2005","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.thromres.2012.02.042_bb0260","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/bmj.321.7273.1382","article-title":"Drug Points: Apparent interaction between warfarin and levonorgestrel used for emergency contraception","volume":"321","author":"Ellison","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2012.02.042_bb0265","series-title":"Medical eligibility criteria for contraceptive use","author":"World Health Organization","year":"2004"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384812000904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384812000904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T12:26:27Z","timestamp":1561465587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384812000904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0049384812000904"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2012.02.042","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}